NSI Retail Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-557
Closed -$504K 31
2024
Q2
$504K Hold
557
0.09% 26
2024
Q1
$433K Sell
557
-200
-26% -$142K 0.06% 33
2023
Q4
$441K Hold
757
0.07% 33
2023
Q3
$407K Sell
757
-850
-53% -$438K 0.09% 29
2023
Q2
$754K Sell
1,607
-1,000
-38% -$419K 0.13% 32
2023
Q1
$895K Hold
2,607
0.19% 24
2022
Q4
$954K Hold
2,607
0.22% 21
2022
Q3
$843K Sell
2,607
-600
-19% -$190K 0.25% 18
2022
Q2
$1.04M Sell
3,207
-1,000
-24% -$300K 0.23% 18
2022
Q1
$1.21M Hold
4,207
0.18% 24
2021
Q4
$1.16M Hold
4,207
0.19% 24
2021
Q3
$972K Hold
4,207
0.17% 24
2021
Q2
$966K Buy
+4,207
New +$845K 0.14% 27

Other funds holding LLY

NSI Retail Advisors's LLY Position: Q3 2024 in Review

NSI Retail Advisors sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 557 shares — an estimated $504K sold.

NSI Retail Advisors first reported a position in LLY in Q2 2021 and held it in 13 quarters. The position peaked at $1.21M in Q1 2022. 3,663 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • NSI Retail Advisors reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • NSI Retail Advisors sold 557 Eli Lilly shares in Q3 2024, an estimated $504K.
  • NSI Retail Advisors first reported a position in Eli Lilly in Q2 2021 and held it in 13 quarters.
  • NSI Retail Advisors's Eli Lilly position peaked at $1.21M in Q1 2022.
  • 3,663 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on NSI Retail Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.